- Home
- ETON vs NXXT Comparison
ETON vs NXXT Comparison
Compare ETON & NXXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- NXXT
- Stock Information
- Founded
- ETON 2017
- NXXT 2019
- Country
- ETON United States
- NXXT United States
- Employees
- ETON N/A
- NXXT N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- NXXT
- Sector
- ETON Health Care
- NXXT
- Exchange
- ETON Nasdaq
- NXXT NYSE
- Market Cap
- ETON 428.5M
- NXXT 390.9M
- IPO Year
- ETON 2018
- NXXT N/A
- Fundamental
- Price
- ETON $17.07
- NXXT $3.06
- Analyst Decision
- ETON Strong Buy
- NXXT
- Analyst Count
- ETON 3
- NXXT 0
- Target Price
- ETON $27.67
- NXXT N/A
- AVG Volume (30 Days)
- ETON 231.3K
- NXXT 47.9K
- Earning Date
- ETON 05-13-2025
- NXXT 05-23-2025
- Dividend Yield
- ETON N/A
- NXXT N/A
- EPS Growth
- ETON N/A
- NXXT N/A
- EPS
- ETON N/A
- NXXT N/A
- Revenue
- ETON $39,011,000.00
- NXXT $27,770,279.00
- Revenue This Year
- ETON $92.33
- NXXT N/A
- Revenue Next Year
- ETON $54.19
- NXXT N/A
- P/E Ratio
- ETON N/A
- NXXT N/A
- Revenue Growth
- ETON 23.29
- NXXT 19.61
- 52 Week Low
- ETON $3.18
- NXXT $2.19
- 52 Week High
- ETON $18.41
- NXXT $7.55
- Technical
- Relative Strength Index (RSI)
- ETON 62.16
- NXXT N/A
- Support Level
- ETON $16.43
- NXXT N/A
- Resistance Level
- ETON $17.74
- NXXT N/A
- Average True Range (ATR)
- ETON 0.92
- NXXT 0.00
- MACD
- ETON 0.06
- NXXT 0.00
- Stochastic Oscillator
- ETON 73.09
- NXXT 0.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About NXXT NEXTNRG INC
NextNRG Inc is engaged in developing an integrated ecosystem that combines solar energy generation, battery storage, smart microgrids, wireless electric vehicle (EV) charging, and on-demand fuel delivery. The company is also focused on combining renewable energy innovation with mobile fueling expertise to build a sustainable energy ecosystem that bridges traditional fuel needs with AI-powered clean energy solutions.